Lactovage in endometriosis

The effect of pretreatment with lactovage on the IVF outcomes of endometriosis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091012002576N48

Enrollment

Registered

2024-10-05

Start date

2024-10-22

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility of other origin

Interventions

Intervention 1: Intervention group: Two weeks before the start of the cycle, patients undergo vaginal examination. The lactovage daily for one week is prescribed. Then, on the second day of menstruat

Eligibility

Sex/Gender

Female

Age

18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Endometriosis patients candidate for FET cycle, embryo grade A orB Embryo grade A orB

Exclusion criteria

Exclusion criteria: Genetic dis., Diabetes Hypertension Autoimmune dis.

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: Bhcg measuerment.;Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Fetal heart activity in transvaginal sonogram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

Fatedavtanha@gmail.com+98 21 8880 0115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026